Proteasome inhibitor Bortezomib/Velcade has emerged as an effective anticancer therapy for the treatment of relapsed and/or refractory multiple myeloma (MM), but prolonged treatment can be associated ...
Explore detailed information about 0052's dividend performance, find the 0052 dividend history and ex-dividend date. This page offers a comprehensive view of 0052's dividend yield payout trends and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results